Low rates of chronic graft-versus-host disease with ruxolitinib maintenance following allogeneic HCT

Journal:

Blood

Published:

2025-05-15

DOI:

10.1182/blood.2024028005

Affiliations:

8

Authors:

19

Go to article

Institutions	Authors	Share
Massachusetts General Hospital (MGH), United States of America (USA)	14.000000 14.000000	0.74
Dana-Farber Cancer Institute (DFCI), United States of America (USA)	1.000000	0.05
Vanderbilt University Medical Center (VUMC), United States of America (USA)	1.000000	0.05
Washington University in St. Louis (WUSTL), United States of America (USA)	1.000000	0.05
Ohio State University Wexner Medical Center (OSUWMC), United States of America (USA)	1.000000	0.05
Medical College of Wisconsin (MCW), United States of America (USA)	1.000000	0.05

Interested in Immunology?